PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
New transdermal therapy available for gout sufferers with negligible systemic absorption improving tolerability and minimizing side effects. ColciGel for Acute Gout Flares is now available at your participating local retail pharmacy. - June 26, 2018 - Gensco Pharma
LayerBio will present preclinical study results at the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii on Monday, April 30. These results demonstrate the therapeutic potential of its novel extended-release travoprost formulation using LayerBio's proprietary PolyNet™ delivery technology. - April 27, 2018 - LayerBio, Inc.
PharmaLink is the New Partner in Drug Returns Processing
Value Drug, a top-rated wholesaler to independent pharmacies, announced another industry leading initiative with PharmaLink. Together they will now provide to all of their members a full array of services in the take back and processing of expired... - March 14, 2018 - PharmaLink
Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12 months.
“Every... - February 21, 2018 - Experimentica Ltd
Creative BioMart, a global leader in the supply of high quality protein products and efficient protein manufacturing techniques, today announced a major expansion of its Protein Glycosylation Labeling Service capacities as a response to rising customer needs and market demands for characterizing glycan... - November 26, 2017 - Creative Biomart
Top executives from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24 – 26 in Messe Frankfurt, Germany.
Tanner Pharma leverages more than 15 years of pharma services experience to provide... - October 21, 2017 - Tanner Pharma Group
Drugshoppe was selected as a finalist in the first annual pitch competition at the Houston Technology Center Innovation Conference and Showcase. Drugshoppe was picked from among many companies that applied in the fields of life sciences, aerospace, energy, IT, and transportation. Drugshoppe will compete... - September 14, 2017 - Drugshoppe
Pharmaceutical company CJSC ARAY announced today that it is in active research and development phase of a new Hormone Replacement Therapy (HRT) drug, called SUSTADREN (TM), housed in Bishkek, Kyrgyz Republic. - August 19, 2017 - CJSC ARAY
Leader in Digital Medicine Will Attend April 27 Event. - April 25, 2017 - Rx.Health
Pioneer in Digital Medicine Expands Northeast Presence - April 19, 2017 - Rx.Health
FDS & myDataMart offer professional, comprehensive and affordable business solutions that immediately impact pharmacy profitability by providing tools to manage patients, third party receivables, Star Ratings, immunization opportunities, MTM cases and much, much more. By providing a deeper look into each pharmacy's data, myDataMart can help better manage pharmacy operations and increase profits. - February 23, 2017 - KeyCentrix
Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately.
Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental in... - October 22, 2016 - Experimentica Ltd
Tabula Rasa HealthCare's (TRHC) Medication Risk Mitigation Matrix(R) brings to Enhanced Medication Therapy Management (EMTM) the ability to identify those Medicare beneficiaries at the highest risk of an adverse drug event and mitigates that risk through personalized interventions. - September 07, 2016 - Tabula Rasa HealthCare
The Dà Má Collective has released "Dissolving The Stigma Against Nature’s Oldest & Safest Medicine: a manifesto," which aims to correct public opinion towards the healing herb known as cannabis. The 7-page illustrated manifesto makes the case, supported by 11,000+ years of hard evidence, that any stigma surrounding the use of cannabis (the notion that cannabis is somehow ‘naughty’) is unfounded and unsustainable. - September 06, 2016 - The Da Ma Collective
Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and
Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC
TruInject Medical Corp™ is pleased to announce the nomination of Innovator of the Year by the Orange County Business Journal. - August 09, 2016 - Truinject Medical Corp.
The Jack Russell Software Innovation Center (JRS IC) announced today its first Coding School Boot Camp will be held September 19, - December 6, 2016. Applications must be submitted between August 1 – September 1, 2016. The JRS IC was launched this year by TRHC to develop technology that will solve real health care problems while providing leading-edge value to software innovation. In celebration, a 50% discount off of the tuition is being offered to students. - August 05, 2016 - Tabula Rasa HealthCare
The new JRS IC will provide technology leadership, creativity and training to TRHC and its subsidiaries, as well as the healthcare community at large. Programs and events are designed to engage and collaborate with highly trained professionals in fields of software development, while creating a culture that continuously innovates and focuses on patient safety. - August 05, 2016 - Tabula Rasa HealthCare
Saffa Compounding Pharmacy is proud to announce its purchase of the Sunshine Care Partners, Tulsa County Territory, and welcomes territory owners Debra Wells DPh, and Karla Taylor, both residents of Tulsa County. Tulsa County physicians serving Chronic Care Patients can partner with Saffa/Sunshine who, after serving the community for over 42 years, is expanding their services to both physicians and patients. - July 07, 2016 - Saffa Compounding Pharmacy
TRHC Chairman and CEO Calvin H. Knowlton named Candy Rebstock Executive Director of its wholly-owned subsidiary, Medliance, which is the leading pharmacy cost management solution for post-acute care. Clients rely on Medliance's adjudication and consulting services to create transparency and increase communication between client skilled nursing facilities and their pharmacy partners. - June 20, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Chairman and CEO, Calvin H. Knowlton, received the 2016 PACT Enterprise Award for Technology CEO of the Year at a gala event in Philadelphia, May 12. While accepting the award, Knowlton stated, "TRHC results include enhanced medication-related outcomes and greater operational efficiency. The work we are doing in medication informatics, personalized medication management, and compliance/assurance is exciting and, we believe, game changing." - June 03, 2016 - Tabula Rasa HealthCare
New Jersey Hospital Association and Tabula Rasa HealthCare (TRHC) have entered into a 3-year agreement to offer TRHC's proprietary Medication Risk Mitigation™ products and services to NJHA’s nearly 400 member healthcare organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc. (TRHC) President Orsula V. Knowlton announced graphic designer, Kristen Propp, has joined the healthcare technology company as Creative Director. TRHC is a leader in providing patient-specific, data-driven technology and solutions for health care organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare CIO Joseph J. Filippoli was honored by SmartCEO Magazine with the 2016 Executive Management Award at a gala celebration March 8. The award recognizes the "leadership and accomplishments of Philadelphia's management all-stars. Winners are recognized for their creative management vision, leadership philosophy, innovative strategy and undeniable work ethic." - March 11, 2016 - Tabula Rasa HealthCare
Company will ask for a single question to show how the pharmaceutical industry can benefit from engaging patient community leaders. - February 24, 2016 - Wego Health
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare and The Greater Philadelphia Business Coalition on Health have partnered to examine the extent of medication risk in a diverse workforce population and the opportunities to mitigate that risk for the benefit of improving the health and welfare of employees and reducing unnecessary health care costs. - February 01, 2016 - Tabula Rasa HealthCare
Under the CMS Enhanced MTM Model, the personalized MTM services offered by Tabula Rasa HealthCare are now eligible for reimbursement by CMS, and for additional performance-based payments. TRHC's Medication Risk Mitigation Matrix(TM) has proven to reduce adverse drug reactions. - October 29, 2015 - Tabula Rasa HealthCare
Calvin H. Knowlton, Chairman and CEO, Tabula Rasa HealthCare, Inc. has been named Individual Health Care Innovator of the Year by the Philadelphia Business Journal. Knowlton is being recognized for his innovation in medication risk mitigation and personalized medicine. - October 20, 2015 - Tabula Rasa HealthCare
Program's goal is to improve the safety of patient medication regimens and patient outcomes using Tabula Rasa's novel and proprietary MRM technolgy platform in tandem with the automated, robotic dispensary of TRHC's CareKinesis Pharmacy. - October 15, 2015 - Tabula Rasa HealthCare
Gensco Laboratories, a specialty pharmaceutical company, has recently introduced a new transdermal prescription medication that provides rapid relief at the first sign of an acute gout flare, ColciGel®, indicated for the treatment and prophylaxis of acute gout flares in adults. ColciGel® is easy to apply directly on the site of pain and each bottle has Metered Dose Technology (MDose™) which dispenses the exact amount of transdermal medication. - October 12, 2015 - Gensco Labs
KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC
KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC
Text “LIDO to 37500” on your mobile device to receive the benefits of the Program
Gensco Laboratories™ (www.genscolabs.com), A Specialty Pharmaceutical Company, announces a new mobile platform that uses innovative smart phone technology to provide copay assistance and facilitate pain... - August 11, 2015 - Gensco Labs
Industry Leader in Pharmacogenomics is now offering inherited cancer screenings for patients to enhance their personalized medical testing services. - July 10, 2015 - GenToX
Creative BioMart, a global leader in the supply of innovative protein research tools and services announced today that it has launched exclusive Oxidative Stress Assay for use in studying many forms of pathophysiology generally associated with aging.
Oxidative stress can reflect a disturbance between... - June 07, 2015 - Creative Biomart
Tabula Rasa HealthCare is recognized for its "innovative solutions that are making an impact on cost, quality, and access in health care." TRHC develops offerings for the ever-growing segment of the healthcare system that is "at risk," providing tools and services to better manage risk. - June 05, 2015 - Tabula Rasa HealthCare
TruInject Medical Corp™ is pleased to announce the development and pending launch of the TruInject Training System, the first injectable simulation system featuring true-to-life tissue, 3D digital facial anatomy and real-time feedback. - June 05, 2015 - Truinject Medical Corp.
The API Sourcing Database is a new Database to find producers of Active Pharmaceutical Ingredients including up to date quality information about the API. - June 02, 2015 - API Sourcing
Creative Biomart, the leading company in the supply of diagnostic antigens and antibodies, pharmaceutical enzymes, diagnostic enzymes, and high-quality recombinant proteins has launched an intuitive new website design as well as coupon promotion. - April 29, 2015 - Creative Biomart
Local genetic testing company is experiencing rapid growth with support from the area’s leading medical professionals in joint efforts to bring personalized medical care to patients. - April 23, 2015 - GenToX
The Award is hosted by Biotechnology Industry Organization at the 2015 BIO International Convention. - April 18, 2015 - GenToX
Peptineo is pleased to announce that Nito Panganiban, Ph.D., has been named Chief Science Officer at Peptineo. Dr. Panganiban will be responsible for cultivating core research capabilities, establishing product development roadmaps, and for communicating with key scientific and customer communities with... - March 20, 2015 - Peptineo
Country Village Chemists of Huntington Asks the Public to Support Their Annual Winter Coat Drive. - February 06, 2015 - North Country Drugs
Boston Healthcare today announced the appointment of Andreas Sander as Vice President and Managing Director for Boston Healthcare International GmbH, leading the European team and the firm’s activities in Germany and Europe out of Boston Healthcare’s Berlin office.
Mr. Sander brings over... - January 21, 2015 - Boston Healthcare
Creative Biomart, a world leading biotech company that specializes in providing advanced tolls for protein expression and purification, today has officially announced its release of novel service--Fucose-free Protein Expression System. According to its official speaker, this service is supported by its... - January 07, 2015 - Creative Biomart
Creative Biomart, a world leading biotech company that provides recombinant proteins, enzymes and other quality products and services for customers all over the world, has announced today that they would launch a special promotion for Christmas and New year in this very day. According to its official... - December 25, 2014 - Creative Biomart
Creative Biomart, a world leading biotech company and the commitment of which is to improving people’s life by assisting scientists with their research, has announced today for its official release of Multiplex Protein Detect Assay Service. This release was said to provide better protein expression... - December 21, 2014 - Creative Biomart
The Lions Eye Institute (LEI) and Experimentica Ltd., a global ophthalmic contract research organization (CRO) announced today that they have entered into an exclusive license agreement for the Akimba mouse model for diabetic retinopathy for contract research. The license agreement was facilitated by Bio-Link Australia, a life sciences commercialisation company. - December 20, 2014 - Experimentica Ltd